Entera Bio Correlations

ENTX Stock  USD 1.57  0.20  11.30%   
The current 90-days correlation between Entera Bio and Anixa Biosciences is 0.1 (i.e., Average diversification). The correlation of Entera Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Moving against Entera Stock

  0.58MRK Merck CompanyPairCorr
  0.51FTV Fortive CorpPairCorr
  0.41TRV The Travelers CompaniesPairCorr
  0.4JPM JPMorgan Chase Earnings Call This WeekPairCorr
  0.38MGMA Metro Global MediaPairCorr
  0.36BAC Bank of America Earnings Call This WeekPairCorr
  0.35MCD McDonaldsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HURASEER
AGENVTGN
VTGNANIX
AGENHURA
AGENANIX
HURAVTGN
  

High negative correlations

AGENABOS
MCRBABOS
SEERIRD
MCRBIRD
ABOSVTGN
HURAIRD

Risk-Adjusted Indicators

There is a big difference between Entera Stock performing well and Entera Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Entera Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANIX  3.96 (0.56) 0.00 (0.19) 0.00 
 9.51 
 40.89 
VTGN  5.62 (0.89) 0.00  0.70  0.00 
 7.93 
 96.59 
IRD  3.07  0.20  0.05  0.27  3.60 
 6.70 
 26.50 
SEER  1.40 (0.35) 0.00 (0.36) 0.00 
 2.71 
 9.98 
HURA  4.42 (1.88) 0.00 (0.56) 0.00 
 7.73 
 50.34 
ABOS  4.48  0.34  0.05  7.72  4.60 
 12.14 
 30.69 
MCRB  4.23 (0.16) 0.00  0.29  0.00 
 9.13 
 54.10 
SPRO  2.42  0.19  0.08  0.18  3.18 
 3.93 
 13.83 
AGEN  2.68 (0.32) 0.00 (0.07) 0.00 
 5.08 
 21.03 
INO  3.86 (0.58) 0.00 (0.61) 0.00 
 7.11 
 36.52 

Entera Bio Corporate Management

Hillel MBAChief OfficerProfile
Miranda MBACEO DirectorProfile
II MDChief OfficerProfile
Gregory BurshteinChief DevelopmentProfile
Dana CPAChief OfficerProfile
Rachel WagmanChief AdvisorProfile
RPh ItinHead BioanalyticsProfile